Final Judgment Of Non-Infringement Entered In Alnylam V. Pfizer Vaccine Patent Dispute
Published:
Aug 14, 2025
On July 30, 2025, the U.S. District Court for the District of Delaware entered a Final Judgment in the dispute between Alnylam Pharmaceuticals, Inc. ("Alnylam") and Pfizer, Inc. ("Pfizer")—concluding that Pfizer's COVID-19 vaccine did not infringe any of Alnylam's patents covering nanoparticle technology. Final Judgment in this case follows behind the Court's order on...
Read More
Read More